ABM Industries Q3 earnings preview: EPS expected at $1.01
- ABM Industries reports Q3 earnings on Sept 8; consensus EPS is $1.01 vs $0.82 YoY
- Revenue estimated at $2.32 billion, up from $2.22 billion in the prior year quarter
- Baird raised price target to $48; UBS and Truist cut targets to $45 in March
- Shares rose 1.7% to $47.23 following better-than-expected Q2 results

*this image is generated using AI for illustrative purposes only.
ABM Industries Incorporated (NYSE: ABM) will release its third-quarter earnings report before the market opens on Tuesday, September 8.
Analysts project the New York-based facility services company to report quarterly earnings per share (EPS) of $1.01, an increase from $0.82 in the year-ago period. The consensus estimate for quarterly revenue stands at $2.32 billion, compared to $2.22 billion reported in the prior year quarter, according to Benzinga Pro data.
Recent Performance Context
The upcoming print follows a better-than-expected second-quarter financial result announced on June 5. Shares of ABM Industries rose 1.7% to close at $47.23 on Thursday.
Analyst Ratings and Price Targets
Several analysts have recently adjusted their views on the stock. Below are the most recent rating changes and price target adjustments from tracked analysts:
| Analyst | Firm | Rating | Price Target | Previous Target | Date | Accuracy |
|---|---|---|---|---|---|---|
| Andrew Wittmann | Baird | Neutral | $48 | $45 | June 8, 2026 | 76% |
| Joshua Chan | UBS | Neutral | $45 | $51 | March 11, 2026 | 55% |
| Jasper Bibb | Truist Securities | Hold | $45 | $47 | March 11, 2026 | 65% |
| David Silver | Freedom Capital Markets | Buy | $54 | N/A | Dec 10, 2025 | 66% |
Baird analyst Andrew Wittmann maintained a Neutral rating while raising the price target to $48. Conversely, UBS and Truist Securities both cut their targets to $45 in March, maintaining Neutral and Hold ratings respectively. Freedom Capital Markets initiated coverage with a Buy rating and a $54 price target in December 2025.
Will ABM Industries' Q3 EPS beat the $1.01 consensus estimate, and how might a miss impact the recent 1.7% post-Q2 rally?
How will the divergence between Freedom Capital's 'Buy' rating and the 'Neutral/Hold' stances of UBS and Truist influence institutional investor sentiment ahead of earnings?
Can ABM sustain its revenue growth trajectory toward $2.32 billion given current macroeconomic pressures on facility services spending?

























